Position in HLN
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$309,532
-$90,777 QoQ
Shares Held
33,176
-17.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#233
of 640 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $3,034,859 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (10.2% of the industry book) .
All Filings in HLN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $309,532 | 33,176 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $400,309 | 39,991 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $315,260 | 31,183 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $118,332 | 13,192 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $132,704 | 12,797 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $133,831 | 13,006 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $132,768 | 13,917 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $144,681 | 13,675 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $124,222 | 15,039 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $118,427 | 13,949 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $91,443 | 11,111 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $90,971 | 10,921 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||